Author claims DRTS is the best stock for 2026 due to a revolutionary cancer treatment, strong clinical results, regulatory progress, experienced team and cash, and upcoming catalysts.
DRTS — LONG The author asserts DRTS has a revolutionary cancer treatment with amazing clinical results, regulatory advancements, an experienced team and a strong cash position, making it the best stock for 2026. The author claims it remains under the radar and therefore undervalued, with many major catalysts expected this year. No specific catalyst, mechanism or risk is detailed.
DRTS has a revolutionary cancer treatment, amazing clinical results, regulatory advancements, experienced team, strong cash position, everything you’d want from a company.
This Reddit post, published January 26, 2026, features u/Pristine_Hurry_4693 discussing DRTS. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Pristine_Hurry_4693 · Tickers: DRTS